In addition, based on TCGA data, significantly longer overall survival times were shown in patients with higher expression of these three hub genes, indicating that EHHADH, ACADM and AGXT2 were prognostic biomarkers for ccRCC (Figures 4B, D, F). The gene discussed is AGXT2; the disease is nonpapillary renal cell carcinoma.